![](/img/cover-not-exists.png)
The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells
Camilla Stapnes, Anne P. Døskeland, Kimberley Hatfield, Elisabeth Ersvær, Anita Ryningen, James B. Lorens, Bjørn Tore Gjertsen, Øystein BruserudVolume:
136
Year:
2007
Language:
english
Pages:
15
DOI:
10.1111/j.1365-2141.2007.06504.x
File:
PDF, 853 KB
english, 2007